These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12137774)

  • 1. An immunoenzymatic solid-phase assay for quantitative determination of HIV-1 protease activity.
    Gutiérrez OA; Salas E; Hernández Y; Lissi EA; Castrillo G; Reyes O; Garay H; Aguilar A; García B; Otero A; Chavez MA; Duarte CA
    Anal Biochem; 2002 Aug; 307(1):18-24. PubMed ID: 12137774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and standardization of an immuno-quantified solid phase assay for HIV-1 aspartyl protease activity and its application to the evaluation of inhibitors.
    Fournout S; Roquet F; Salhi SL; Seyer R; Valverde V; Masson JM; Jouin P; Pau B; Nicolas M; Hanin V
    Anal Chem; 1997 May; 69(9):1746-52. PubMed ID: 9145028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of HIV-1 protease activity by use of crude preparations of enzyme and biotinylated substrate.
    Yu SL; Wang N; Liou CY; Syu WJ
    J Virol Methods; 1995 May; 53(1):63-73. PubMed ID: 7635927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
    Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
    Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a mammalian cell-based assay for monitoring the HIV-1 protease activity.
    Rajakuberan C; Hilton BJ; Wolkowicz R
    Methods Mol Biol; 2012; 903():393-405. PubMed ID: 22782834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microtiter colorimetric assay for the HIV-1 protease.
    Stebbins J; Debouck C
    Anal Biochem; 1997 Jun; 248(2):246-50. PubMed ID: 9177750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug discovery platform: a simplified immunoassay for analyzing HIV protease activity.
    Kitidee K; Nangola S; Hadpech S; Laopajon W; Kasinrerk W; Tayapiwatana C
    J Virol Methods; 2012 Dec; 186(1-2):21-9. PubMed ID: 22846787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid enzymatic test for phenotypic HIV protease drug resistance.
    Hoffmann D; Assfalg-Machleidt I; Nitschko H; von der Helm K; Koszinowski U; Machleidt W
    Biol Chem; 2003 Jul; 384(7):1109-17. PubMed ID: 12956428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary crystallographic studies of an anti-HIV-1 protease antibody that inhibits enzyme activity.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    Protein Sci; 1996 May; 5(5):966-8. PubMed ID: 8732768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode.
    Mahmoud KA; Luong JH
    Anal Chem; 2008 Sep; 80(18):7056-62. PubMed ID: 18707132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic profiling of substrate binding response to multidrug-resistant mutations in HIV-1 protease: Implication for combating drug resistance.
    Lv Y; Li J; Fang J; Jiao X; Yan L; Shan B
    J Mol Graph Model; 2017 Jun; 74():83-88. PubMed ID: 28371730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fast and robust 19F NMR-based method for finding new HIV-1 protease inhibitors.
    Frutos S; Tarrago T; Giralt E
    Bioorg Med Chem Lett; 2006 May; 16(10):2677-81. PubMed ID: 16517158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioluminescence detection of proteolytic bond cleavage by using recombinant aequorin.
    Deo SK; Lewis JC; Daunert S
    Anal Biochem; 2000 May; 281(1):87-94. PubMed ID: 10847614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure.
    Marastoni M; Bazzaro M; Salvadori S; Bortolotti F; Tomatis R
    Bioorg Med Chem; 2001 Apr; 9(4):939-45. PubMed ID: 11354677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automation of a high-performance liquid chromatography-based enzyme assay: evaluation of inhibition constants for human immunodeficiency virus-1 protease inhibitors.
    Pazhanisamy S; Stuver CM; Livingston DJ
    Anal Biochem; 1995 Jul; 229(1):48-53. PubMed ID: 8533894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
    Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
    Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro translation to study HIV protease activity.
    Matsuda Z; Iga M; Miyauchi K; Komano J; Morishita K; Okayama A; Tsubouchi H
    Methods Mol Biol; 2007; 375():135-49. PubMed ID: 17634600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.